Gilbert syndrome
Enzyme or protein defect
UGT1A1 (reduced activity)
Accumulates or becomes deficient
Unconjugated bilirubin
Key features
Mild intermittent jaundice with fasting, illness or stress; otherwise benign
Management
Reassurance
Not clinical guidance. Written from standard clinical biochemistry, not from the uploaded documents, and marked unreviewed. Teaching-level reference for study and database seeding only. It must not be used to manage a patient.
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Low Phospholipid-Associated Cholelithiasis in a Mother-Son Pair Associated With a Novel <i>ABCB4</i> Frameshift Variant.
Yang HM, Liu J, Zhang Z. · 2026-10-02
open access unreviewed -
2
Bilirubin and the Yellow Players in Ferroptosis: A Delicate Balance in Human Health and Disease, with a Focus on the Liver, Cardiovascular System, and Brain.
Dalla Verde C, Vitek L, Tiribelli C, Gazzin S. · 2026-09-21
open access unreviewed -
3
A Tarui Disease Phenotype with Compensated Hemolysis and a Homozygous <i>PFKM</i> Variant of Uncertain Significance Mimicking Chronic Myelomonocytic Leukemia.
Neculcea AC, Aanicai R, Massoto B, Nistor RI, Fierbințeanu-Braticevici C, Mambet C, Mititelu A, Neagu AM, Par… · 2026-09-07
open access unreviewed -
4
Hyperbilirubinemia following an acetaminophen (paracetamol) overdose in a patient with undiagnosed gilbert syndrome.
Haws B, Knowles T, Arens AM. · 2026-09-14
unreviewed -
5
X-linked myotubular myopathy, liver disease, and gene therapy.
Pannia E, Karolczak S, Stine R, Dowling JJ. · 2026-09-09
open access unreviewed -
6
Diagnostic Pitfall in β-Thalassemia Trait Screening: A Case of Hb Showa-Yakushiji (<i>HBB</i>:c.332T > C) Coinherited with Gilbert Syndrome.
Taak R, Jamwal M, Singh N, Sharma P, Hira JK, Chhabra S, Bansal D, Maitra A, Das R. · 2026-01-03
unreviewed -
7
Real-world prevalence and prognostic significance of hepatotoxicity after chimeric antigen receptor T-cell therapy.
Hollnberger J, Richardson T, Gödel P, Leutiger J, Schumacher JC, Schiestel S, Allhoff B, Scheid C, Holtick U,… · 2026-07-07
open access unreviewed -
8
CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome∗
Alvarado Y, Senapati J, Kadia T, Borthakur G, Montalban-Bravo G, Short N, Daver N, DiNardo C, Masarova L, Fer… · 2026-08-25
open access unreviewed -
9
The Liver as a Biomarker Organ in Heart Failure: Molecular Mechanisms, Hepatic Scores and Systemic Risk Stratification.
Szczurek-Wasilewicz W, Borowiec A, Waluszewska I, Szyguła-Jurkiewicz B. · 2026-08-23
open access unreviewed -
10
Clinical evaluation of low-dose radiation therapy for immunotherapy resistance in advanced non-small cell lung cancer.
Fu DJ, Daleng GW, Wang WJ, Gao JL, Wuyun GW, Han YL, Tian D, Deng SQ, Li QF. · 2026-08-27
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.